The company's financial profile shows increasing leverage, with total debt rising to $362.8 million in 2026Q1, pushing the debt-to-equity ratio to 0.46.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 139.11M | 139.99M | 137.58M | 233.38M | 111.27M | 95.17M | 87.64M | 85.39M | 79.21M | 77.08M | 65.96M | 60.18M | 54.85M | 49.66M | 45.32M | 45.67M | 39.28M | 32.84M | 38.72M | 36.03M | 35.98M | 36.85M | 40.61M | 33.02M | 23.08M | 22.41M | 13.74M | 14.65M | 15.6M | 14M | 11.8M |
| Cash & Short-Term Investments | 28.44M | 35.57M | 41.36M | 152.82M | 31.59M | 28.57M | 32.92M | 23.55M | 23.37M | 21.93M | 20.05M | 15.78M | 14.27M | 12.9M | 11.67M | 9.98M | 9.18M | 6.43M | 10.11M | 7.98M | 11.45M | 15M | 20.55M | 16.82M | 7.61M | 8.12M | 2.07M | 4.03M | 6.3M | 5.6M | 4.9M |
| Cash Only | 28.44M | 35.57M | 41.36M | 152.82M | 31.59M | 28.57M | 32.92M | 23.55M | 23.37M | 21.93M | 20.05M | 15.78M | 14.27M | 12.9M | 11.67M | 9.98M | 9.18M | 6.43M | 10.11M | 7.98M | 10.95M | 15M | 20.55M | 16.82M | 7.61M | 8.12M | 2.07M | 4.03M | 6.3M | 5.6M | 4.9M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 500K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 96.72M | 64.25M | 85.67M | 51.87M | 68.61M | 62.42M | 50.95M | 56.05M | 51.49M | 50.36M | 41.49M | 38.62M | 34.59M | 32.66M | 27.68M | 29.95M | 26.37M | 23.63M | 26.75M | 26.72M | 22.28M | 20.42M | 18.22M | 14.4M | 13.68M | 13.65M | 11.15M | 9.99M | 8.7M | 7.9M | 6.5M |
| Days Sales Outstanding | 45.37 | 30.03 | 46.58 | 31.3 | 45.27 | 46.02 | 43.96 | 42.45 | 41.41 | 44.4 | 42.47 | 42.55 | 41.39 | 45.15 | 40.07 | 46.12 | 45.56 | 42.82 | 52.02 | 64.31 | 60.15 | 56.42 | 56.21 | 49.79 | 52.7 | 61.54 | 64.39 | 73.01 | 72.17 | 74.32 | 73.68 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 13.95M | 40.17M | 10.55M | 28.68M | 11.07M | 4.18M | 3.77M | 5.79M | 11.1M | 10.44M | 7.08M | 8.19M | 7.69M | 5.94M | 7.68M | 7.35M | 3.74M | 2.96M | 1.86M | 1.33M | 2.25M | 1.43M | 1.83M | 1.8M | 1.79M | 646K | 519K | 630K | 600K | 500K | 400K |
| Total Non-Current Assets | 1.1B | 1.06B | 1.03B | 763.86M | 746.89M | 654.26M | 506.73M | 475.46M | 363.95M | 341.9M | 285.27M | 219.73M | 189.7M | 174.47M | 126.39M | 117.58M | 101.58M | 78.41M | 79.53M | 60.22M | 35.48M | 29.67M | 21M | 19.45M | 17.95M | 13.77M | 9.23M | 8.7M | 8.5M | 8.5M | 7.7M |
| Property, Plant & Equipment | 187.82M | 271.07M | 166.08M | 129.53M | 127.75M | 119.41M | 103.26M | 103.68M | 20.17M | 20.39M | 19.17M | 16.65M | 15.76M | 14.96M | 13.02M | 13.19M | 13.92M | 14.34M | 15.84M | 16.79M | 13.37M | 13.74M | 13.65M | 11.81M | 10.41M | 7.8M | 6.99M | 6.49M | 6.4M | 6M | 6M |
| Fixed Asset Turnover | 3.47x | 2.88x | 4.04x | 4.67x | 4.33x | 4.15x | 4.10x | 4.65x | 22.51x | 20.31x | 18.60x | 19.89x | 19.35x | 17.65x | 19.37x | 17.97x | 15.17x | 14.05x | 11.85x | 9.03x | 10.11x | 9.62x | 8.67x | 8.94x | 9.10x | 10.37x | 9.04x | 7.70x | 6.88x | 6.47x | 5.37x |
| Goodwill | 715.87M | 692.39M | 667.15M | 509.57M | 494.1M | 434.68M | 345.65M | 317.68M | 293.52M | 271.34M | 226.81M | 171.55M | 147.91M | 143.96M | 100.19M | 92.75M | 79.42M | 57.25M | 55.89M | 37.65M | 21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 179.82M | 172.86M | 179.31M | 109.68M | 108.75M | 86.38M | 56.28M | 52.59M | 48.83M | 48.95M | 38.06M | 30.3M | 24.91M | 14.48M | 12.15M | 9.6M | 7.31M | 5.96M | 6.45M | 3.93M | 0 | 14.34M | 6.13M | 5.68M | 5.59M | 4.52M | 897K | 948K | 1M | 1.2M | 800K |
| Long-Term Investments | 49.33M | 12.28M | 12.19M | 12.26M | 12.13M | 12.21M | 0 | 0 | -2.48M | -2.06M | -2.54M | -2.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 6.99M | -84.58M | 5.16M | 2.82M | 4.15M | 1.58M | 1.54M | 1.52M | 1.43M | 1.22M | 1.23M | 1.23M | 1.11M | 1.08M | 1.04M | 2.04M | 922K | 869K | 1.35M | 1.85M | 1.11M | 1.59M | 1.23M | 1.96M | 1.95M | 1.45M | 1.34M | 1.26M | 1.1M | 1.3M | 900K |
| Total Assets | 1.24B | 1.2B | 1.17B | 997.24M | 858.15M | 749.43M | 594.36M | 560.85M | 443.17M | 418.98M | 351.23M | 279.91M | 244.55M | 224.13M | 171.71M | 163.25M | 140.86M | 111.25M | 118.25M | 96.25M | 71.46M | 66.52M | 61.61M | 52.47M | 41.03M | 36.18M | 22.97M | 23.35M | 24.1M | 22.5M | 19.5M |
| Asset Turnover | 0.58x | 0.65x | 0.58x | 0.61x | 0.64x | 0.66x | 0.71x | 0.86x | 1.02x | 0.99x | 1.02x | 1.18x | 1.25x | 1.18x | 1.47x | 1.45x | 1.50x | 1.81x | 1.59x | 1.58x | 1.89x | 1.99x | 1.92x | 2.01x | 2.31x | 2.24x | 2.75x | 2.14x | 1.83x | 1.72x | 1.65x |
| Asset Growth % | 39.94% | 3.13% | 17.07% | 16.21% | 14.51% | 26.09% | 5.98% | 26.55% | 5.77% | 19.29% | 25.48% | 14.46% | 9.11% | 30.53% | 5.18% | 15.9% | 26.61% | -5.91% | 22.85% | 34.7% | 7.42% | 7.97% | 17.41% | 27.88% | 13.4% | 57.53% | -1.61% | -3.13% | 7.11% | 15.38% | 22.64% |
| Total Current Liabilities | 117.3M | 139.04M | 116.28M | 102.19M | 85.49M | 83.48M | 93.49M | 60.56M | 41.95M | 39.55M | 24.62M | 19.01M | 25.5M | 23.17M | 16.31M | 16.32M | 14.23M | 14.59M | 14.61M | 11.44M | 9.17M | 7.12M | 5.62M | 5.42M | 2.85M | 3.25M | 3.32M | 2.16M | 2.6M | 2.8M | 2.6M |
| Accounts Payable | 6.76M | 6.06M | 5.94M | 3.9M | 6.5M | 6.47M | 1.33M | 2.49M | 2.02M | 2.17M | 1.63M | 1.64M | 1.78M | 1.72M | 1.73M | 1.81M | 1.24M | 1.29M | 1.48M | 1.55M | 1.6M | 1.72M | 1.18M | 498K | 624K | 539K | 434K | 349K | 600K | 300K | 300K |
| Days Payables Outstanding | 4.11 | 3.55 | 3.96 | 2.94 | 5.38 | 6.25 | 1.48 | 2.46 | 2.09 | 2.44 | 2.17 | 2.36 | 2.84 | 3.15 | 3.34 | 3.83 | 2.97 | 3.22 | 3.86 | 4.96 | 5.88 | 6.53 | 5.05 | 2.44 | 3.53 | 3.58 | 3.69 | 3.74 | 7.11 | 4.01 | 4.95 |
| Short-Term Debt | 53.58M | 52M | 11M | 7.69M | 7.86M | 830K | 4.9M | 728K | 1.43M | 4.04M | 1.23M | 775K | 883K | 825K | 459K | 433K | 250K | 1.01M | 1.38M | 812K | 562K | 244K | 70K | 2.37M | 4K | 701K | 912K | 39K | 0 | 100K | 100K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -175K | 0 | 0 | 0 | 0 | 0 | 0 | 2.19M | 1.9M | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 56.96M | 80.98M | 0 | 22.49M | 0 | 0 | 0 | 0 | 16.77M | 9.52M | 11.19M | 5.71M | 5.61M | 6.57M | 2.85M | 4.01M | 3.75M | 3.33M | 5.25M | 4.17M | 4.76M | 3.01M | 0 | 0 | 33K | -445K | 1.98M | 1.77M | 2M | 2.4M | 2.2M |
| Current Ratio | 1.19x | 1.01x | 1.18x | 2.28x | 1.30x | 1.14x | 0.94x | 1.41x | 1.89x | 1.95x | 2.68x | 3.17x | 2.15x | 2.14x | 2.78x | 2.80x | 2.76x | 2.25x | 2.65x | 3.15x | 3.92x | 5.18x | 7.23x | 6.09x | 8.10x | 6.90x | 4.14x | 6.79x | 6.00x | 5.00x | 4.54x |
| Quick Ratio | 1.19x | 1.01x | 1.18x | 2.28x | 1.30x | 1.14x | 0.94x | 1.41x | 1.89x | 1.95x | 2.68x | 3.17x | 2.15x | 2.14x | 2.78x | 2.80x | 2.76x | 2.25x | 2.65x | 3.15x | 3.92x | 5.18x | 7.23x | 6.09x | 8.10x | 6.90x | 4.14x | 6.79x | 6.00x | 5.00x | 4.54x |
| Cash Conversion Cycle | 41.25 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 341.89M | 294.77M | 292.14M | 242.81M | 288.1M | 213.5M | 90.9M | 120.83M | 50.4M | 70.46M | 68.74M | 58.95M | 44.46M | 45.84M | 20.75M | 25.35M | 10.25M | 4.44M | 15.81M | 9.76M | 2.9M | 2.9M | 2.5M | 429K | 2.62M | 3.02M | 7.23M | 8.09M | 8.2M | 8.1M | 8.3M |
| Long-Term Debt | 194.04M | 263.17M | 142.53M | 138.99M | 175.83M | 117.59M | 16.6M | 50.36M | 38.4M | 56.73M | 50.6M | 48.34M | 34.73M | 40.65M | 17.57M | 23.78M | 5.75M | 400K | 12.41M | 7.96M | 797K | 483K | 0 | 83K | 2.35M | 3.02M | 7.23M | 8.09M | 8.1M | 8.2M | 8.3M |
| Capital Lease Obligations | 436.24M | 110.57M | 101.87M | 76.65M | 77.93M | 74.19M | 61.98M | 60.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 129.26M | 28.39M | 29.46M | 24.82M | 21.3M | 14.38M | 7.78M | 10.07M | 9.01M | 10.88M | 15.74M | 9.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.86M | -107.36M | 18.27M | 2.36M | 13.03M | 7.34M | 4.54M | 141K | 12M | 13.73M | 18.14M | 1.4M | 9.72M | 5.19M | 3.17M | 623K | 3.53M | 3.01M | 3.4M | 1.8M | 2.1M | 2.42M | 2.5M | 346K | 273K | 0 | 0 | 0 | 100K | -100K | 0 |
| Total Liabilities | 459.19M | 433.81M | 408.42M | 345M | 373.59M | 296.98M | 184.39M | 181.39M | 92.35M | 110.01M | 93.35M | 77.96M | 69.96M | 69.01M | 37.05M | 41.67M | 24.48M | 19.03M | 30.43M | 21.2M | 12.07M | 10.02M | 8.12M | 5.85M | 5.47M | 6.27M | 10.55M | 10.24M | 10.8M | 10.9M | 10.9M |
| Total Debt | 362.83M | 425.74M | 295.23M | 258.59M | 295.34M | 223.08M | 110.99M | 137.83M | 39.84M | 60.77M | 51.82M | 49.11M | 35.62M | 41.48M | 18.03M | 24.22M | 6M | 1.41M | 13.79M | 8.77M | 1.36M | 727K | 70K | 2.46M | 2.35M | 3.72M | 8.14M | 8.13M | 8.1M | 8.3M | 8.4M |
| Net Debt | 334.39M | 390.17M | 253.87M | 105.76M | 263.74M | 194.51M | 78.07M | 114.28M | 16.47M | 38.84M | 31.78M | 33.33M | 21.35M | 28.58M | 6.36M | 14.23M | -3.18M | -5.02M | 3.68M | 795K | -9.59M | -14.28M | -20.48M | -14.37M | -5.26M | -4.4M | 6.07M | 4.1M | 1.8M | 2.7M | 3.5M |
| Debt / Equity | 0.46x | 0.55x | 0.39x | 0.40x | 0.61x | 0.49x | 0.27x | 0.36x | 0.11x | 0.20x | 0.20x | 0.24x | 0.20x | 0.27x | 0.13x | 0.20x | 0.05x | 0.02x | 0.16x | 0.12x | 0.02x | 0.01x | 0.00x | 0.05x | 0.07x | 0.12x | 0.66x | 0.62x | 0.61x | 0.72x | 0.98x |
| Debt / EBITDA | 3.32x | 4.14x | 3.61x | 3.82x | 4.13x | 2.71x | 1.76x | 1.78x | 0.57x | 0.94x | 0.89x | 0.89x | 0.68x | 0.94x | 0.42x | 0.59x | 0.15x | 0.04x | 0.46x | 0.35x | 0.06x | 0.03x | 0.00x | 0.12x | 0.11x | 0.19x | 0.64x | 0.87x | 1.07x | 1.24x | 1.58x |
| Net Debt / EBITDA | 3.06x | 3.79x | 3.10x | 1.56x | 3.69x | 2.37x | 1.24x | 1.47x | 0.24x | 0.60x | 0.54x | 0.60x | 0.41x | 0.64x | 0.15x | 0.34x | -0.08x | -0.15x | 0.12x | 0.03x | -0.42x | -0.62x | -1.01x | -0.70x | -0.24x | -0.23x | 0.48x | 0.44x | 0.24x | 0.40x | 0.66x |
| Interest Coverage | 8.24x | 9.23x | 8.51x | 6.31x | 10.62x | 78.70x | 41.09x | 35.11x | 30.49x | 2.60x | 4.32x | 6.54x | 6.14x | 72.08x | 68.96x | 74.34x | 143.12x | 80.28x | 44.53x | 66.56x | - | - | - | 89.64x | 87.79x | 63.71x | 13.31x | 9.99x | 7.86x | - | 5.14x |
| Total Equity | 782.87M | 769.74M | 759.05M | 652.24M | 484.57M | 452.44M | 409.97M | 379.45M | 350.82M | 308.97M | 257.88M | 201.95M | 174.59M | 155.12M | 134.66M | 121.58M | 116.38M | 92.22M | 87.82M | 75.06M | 59.39M | 56.5M | 53.49M | 46.63M | 35.56M | 29.91M | 12.42M | 13.1M | 13.3M | 11.6M | 8.6M |
| Equity Growth % | 35.48% | 1.41% | 16.38% | 34.6% | 7.1% | 10.36% | 8.04% | 8.16% | 13.54% | 19.81% | 27.69% | 15.67% | 12.55% | 15.2% | 10.76% | 4.47% | 26.19% | 5.01% | 17.01% | 26.38% | 5.11% | 5.63% | 14.72% | 31.11% | 18.87% | 140.84% | -5.2% | -1.48% | 14.66% | 34.88% | 45.76% |
| Book Value per Share | 51.62 | 50.72 | 50.39 | 45.97 | 37.32 | 35.08 | 31.94 | 29.75 | 27.70 | 24.58 | 20.63 | 16.30 | 14.29 | 12.84 | 11.31 | 10.15 | 9.80 | 7.81 | 7.29 | 6.41 | 5.08 | 4.69 | 4.33 | 3.88 | 2.81 | 2.33 | 1.16 | 1.33 | 1.23 | 1.07 | 0.81 |
| Total Shareholders' Equity | 468.98M | 476.43M | 488.93M | 476.19M | 315.79M | 295.61M | 276.16M | 240.26M | 215.94M | 204.87M | 187.55M | 162.78M | 146.28M | 128.29M | 117.32M | 107.05M | 103.96M | 87.35M | 81.61M | 69.41M | 55.52M | 53.48M | 50.18M | 43.35M | 32.54M | 26.67M | 9.56M | 10.72M | 11.6M | 10M | 7.6M |
| Common Stock | 175K | 174K | 172K | 172K | 152K | 151K | 151K | 150K | 149K | 148K | 147K | 146K | 145K | 143K | 141K | 139K | 139K | 138K | 142K | 141K | 137K | 136K | 134K | 122K | 118K | 107K | 57K | 36K | 0 | 0 | 0 |
| Retained Earnings | 216.88M | 227.22M | 227.26M | 223.77M | 232.95M | 224.4M | 212.01M | 184.35M | 167.4M | 162.41M | 150.34M | 149.02M | 134.19M | 119.21M | 111.32M | 102.41M | 89.88M | 81.21M | 69.45M | 59.44M | 50.7M | 44.41M | 35.62M | 28.94M | 21.61M | 13.12M | 6.05M | 2.31M | -100K | -1.7M | -4.1M |
| Treasury Stock | -37.19M | -37.19M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -26.11M | -18.11M | -12.52M | -12.5M | -1.99M | -47K | -47K | 0 | 0 | 0 |
| Accumulated OCI | 978K | 714K | 2.8M | 2.78M | 4M | 0 | 0 | 0 | -64.15M | -60.48M | -56.02M | -53.26M | -49.05M | 0 | -44.16M | -42.3M | -39.23M | -36.65M | -33.17M | -29.34M | -25.57M | -23.82M | -23.04M | -19.55M | -16.69M | -13.8M | -11.46M | -3.45M | -7.6M | -6M | -4.3M |
| Minority Interest | 313.9M | 293.31M | 270.12M | 176.04M | 168.78M | 156.84M | 133.81M | 139.19M | 134.87M | 104.1M | 70.33M | 39.17M | 28.31M | 26.83M | 17.34M | 14.53M | 12.43M | 4.87M | 6.21M | 5.65M | 3.87M | 3.02M | 3.31M | 3.28M | 3.02M | 3.25M | 2.86M | 2.38M | 1.7M | 1.6M | 1M |
Goodwill impairment and leverage
According to recent financial statements, USPH has seen total assets grow to $1.2 billion by 2026Q1, yet this expansion is increasingly funded by debt rather than internal cash accumulation, signaling a shift toward a more aggressive, leverage-dependent growth trajectory that warrants close monitoring by institutional investors.
The company's asset base has remained relatively static at $1.2 billion over the last five quarters, masking a significant underlying shift in composition toward higher goodwill and PPE. This suggests that the firm is prioritizing inorganic expansion through acquisitions, which may be necessary to offset organic volume stagnation but introduces execution risk regarding the integration of these new clinical assets.
As reported in quarterly filings, USPH's total debt climbed to $362.8 million in 2026Q1 from a low of $254.3 million in 2024Q3, pushing the debt-to-equity ratio to 0.46 and indicating that the company is increasingly utilizing external financing to fund its ongoing clinic acquisition strategy.
While a debt-to-equity ratio of 0.46 remains manageable within the healthcare services sector, the upward trend in leverage suggests that the company's internal cash generation may be insufficient to support its desired pace of expansion. Investors should consider whether this increased reliance on debt will constrain future financial flexibility, particularly if reimbursement headwinds continue to pressure operating margins.
Based on the latest balance sheet data, goodwill has ballooned to $715.9 million as of 2026Q1, representing a significant portion of the $1.2 billion total asset base, which suggests that the company's valuation is increasingly sensitive to the long-term performance of its acquired clinical partnerships.
The high concentration of intangible assets relative to tangible PPE reflects the premium paid for clinic acquisitions and the underlying partnership model. This composition implies that any sustained decline in the profitability of these acquired clinics could necessitate significant impairment charges, potentially impacting the company's book value and overall financial health.
According to reported figures, USPH's cash position has dwindled to $28.4 million in 2026Q1, down sharply from the $152.8 million held in 2023Q4, which indicates a narrowing liquidity buffer as the company aggressively deploys capital toward acquisitions and operational requirements.
The current ratio of 1.19 suggests that while the company maintains sufficient short-term liquidity to meet its immediate obligations, the significant reduction in cash reserves limits its ability to absorb unexpected operational shocks. This trend warrants further investigation into whether the company's working capital management is becoming overly strained by its current growth-at-all-costs strategy.
Quick answers to the most common questions about buying USPH stock.
As of 2025, U.S. Physical Therapy, Inc. (USPH) had total assets of $1.20B including $140.0M in current assets.
U.S. Physical Therapy, Inc. (USPH) carries total debt of $425.7M, offset by $35.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
U.S. Physical Therapy, Inc. (USPH) has total shareholders' equity (book value) of $476.4M ($50.72 book value per share). Book value represents the net worth of the company belonging to common stock holders.
U.S. Physical Therapy, Inc. (USPH) reported a current ratio of 1.01x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.